This article is more than 5 years old. Information may no longer be current.

VIDEO: Patients with gout, type 2 diabetes require more aggressive management

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

SAN DIEGO — At the American College of Rheumatology Annual Meeting, Machelle Manuel, PhD, vice president of medical scientific affairs at Ironwood Pharmaceuticals, discussed study findings that examined potential associations of type 2 diabetes and gout with clinical outcomes, as well as variations in gout severity, management and health care use among patients with both conditions.

Manuel noted that patients with both gout and type 2 diabetes were more likely to have a greater impact on health spending, with additional comorbidities and more severe gout than those without type 2 diabetes. She added that this suggests that patients with both conditions need careful monitoring and more aggressive gout management.